New antitumor substances, FR901463, FR901464 and FR901465: I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities

Journal of Antibiotics

Volumn 49, Issue 12, 1996, Pages 1196-1203

  Nakajima, Hidenori ^a   Sato, Bunji ^a   Fujita, Takashi ^a   Takase, Shigehiro ^a   Terano, Hiroshi ^a   Okuhara, Masakuni ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FR 901463; FR 901464; FR 901465; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; FERMENTATION; HUMAN; HUMAN CELL; INFRARED SPECTROMETRY; LD 50; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROTON NUCLEAR MAGNETIC RESONANCE; SIMIAN VIRUS 40; TAXONOMY; VIRUS TRANSCRIPTION;

EID: 0030461311     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.49.1196     Document Type: Article

References (15)

1. LOWE, S. W. & H. E. RULEY: Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes & Dev. 7: 535-545, 1993
2. waf 1/cip 1. Genes & Dev. 8: 2817-2830, 1996
3. Wu, X. & A. J. LEVINE: p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. U.S.A. 91: 3602-3606, 1994
4. TAN, T. M. C. & R. C. Y. TING: In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res. 55: 4599-4605, 1995
5. EASTHAM, J. A.; S. J. HALL, I. SEHGAL, J. WANG, T. L. TIMME, G. YANG, L. CONNELL-CROWLEY, S. J. ELLEDGE, W. ZHANG, J. W. HARPER & T. C. THOMPSON: In vitro gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res. 55: 5151-5155, 1995
6. YANG, Z.; N. D. PERKINS, T. OHNO, E. G. NABEL & G. J. NABEL: The p21 cyclindependent kinase inhibitor suppresses tumorigenicity in vitro. Nature Medicine 1: 1052-1056, 1995
7. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11: 493-504, 1995
8. KOHL, N. E.; S. D. MOSSER, S. J. DESOLMS, E. A. GIULIANI, D. L. POMPLIANO, S. L. GRAHAM, R. L. SMITH, E. M. SCOLNICK, A. OLIFF & J. B. GIBBS: Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260: 1934-1937, 1993
9. UEDA, H.; H. NAKAJIMA, Y. HORI, T. FUJITA, M. NISHIMURA, T. GOTO & M. OKUHARA: FR901228, a novel antitumor bicyclic depsipeptide produced by chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J. Antibiotics 47: 301-310, 1994
10. JONES, N. C.; P. W. J. RIGBY & E. B. ZIFF: Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes & Dev. 2: 267-281, 1988
11. SNEATH, P. H. A.: Genus Chromobacterium Bergonzini 1881, 153. In BERGEY'S Manual of Systemic Bacteriology 9th Edition Vol. 1., Eds., N. R. KRIEG & J. G. HOLT, pp. 580-582, Williams & Wilkins Co., Baltimore, 1984
12. CHEN, C. & H. OKAYAMA : High-efficiency transformation of mammalian cell by plasmid DNA. Mol. Cell Biol. 7: 2745-2752, 1987
13. MOSMANN, T.: Rapid colorimetric assay for cellular growth and survival; Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63, 1983
14. NAKAJIMA, H.; Y. HORI, H. TERANO, M. OKUHARA, T. MANDA, S. MATSUMOTO & K. SHIMOMURA: New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action. J. Antibiotics 49: 1204-1211, 1996
15. NAKAJIMA, H.; H. HORI, T. GOTO, S. TAKASE, K. VERHAEGHE, H. TERANO & M. OKUHARA (Fujisawa): Substance WB2663, production thereof and use. Eur. Pat. Appl. 0 591 534 A1, Jun 12, 1992